Krämer, B., Hauske, S. J., Chilton, R., Mann, J. F. E., Gullestad, L., Fitchett, D., . . . Wanner, C. (2023). Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetes. Journal of diabetes and its complications, 37(9), . https://doi.org/10.1016/j.jdiacomp.2023.108588
Chicago-Zitierstil (17. Ausg.)Krämer, Bernhard, Sibylle J. Hauske, Robert Chilton, Johannes F. E. Mann, Lars Gullestad, David Fitchett, Michaela Mattheus, Dominik Steubl, und Christoph Wanner. "Changes in Cardiac and Vascular Haemodynamics as Potential Mediators of Improvements in Cardiovascular and Kidney Outcomes with Empagliflozin in Type 2 Diabetes." Journal of Diabetes and Its Complications 37, no. 9 (2023). https://doi.org/10.1016/j.jdiacomp.2023.108588.
MLA-Zitierstil (9. Ausg.)Krämer, Bernhard, et al. "Changes in Cardiac and Vascular Haemodynamics as Potential Mediators of Improvements in Cardiovascular and Kidney Outcomes with Empagliflozin in Type 2 Diabetes." Journal of Diabetes and Its Complications, vol. 37, no. 9, 2023, https://doi.org/10.1016/j.jdiacomp.2023.108588.